Get ASMBS 2023 OnDemand Now! Learn More About OnDemand

Learn about the prevalence of postoperative pain, opioid use, nausea, and vomiting, and their impact on patient satisfaction, clinical outcomes, and cost. Explore the benefits of the first and only extended-release dual-acting local anesthetic (DALA) proven to reduce postoperative pain for up to 72 hours and reduce or eliminate the need for opioids in many patients. Understand the value of, a proven, effective antiemetic with a 48-hour duration of action and a comparable safety profile to IV ondansetron.

Join Us for this Breakfast Symposium!

Register to attend!

This is a NON-CME event.